No interruption of lactation is needed after (11)C-WAY 100635 or (11)C-raclopride PET

J Nucl Med. 2005 Oct;46(10):1765.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Female
  • Humans
  • Lactation / metabolism*
  • Milk, Human / chemistry*
  • Piperazines / analysis
  • Piperazines / pharmacokinetics*
  • Positron-Emission Tomography / methods
  • Pyridines / analysis
  • Pyridines / pharmacokinetics*
  • Raclopride / analysis
  • Raclopride / pharmacokinetics*
  • Radiation Dosage
  • Radiometry / methods*
  • Radiopharmaceuticals / analysis
  • Radiopharmaceuticals / pharmacokinetics
  • Risk Assessment / methods*
  • Risk Factors

Substances

  • Piperazines
  • Pyridines
  • Radiopharmaceuticals
  • Raclopride
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide